- Home
- ARKO vs RCKT Comparison
ARKO vs RCKT Comparison
Compare ARKO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARKO | RCKT |
|---|---|---|
| Founded | 1970 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.3M | 394.2M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ARKO | RCKT |
|---|---|---|
| Price | $4.74 | $3.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $7.50 | ★ $29.73 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | 15.38 | ★ 26.37 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $9,142,799,000.00 | N/A |
| Revenue This Year | $12.86 | N/A |
| Revenue Next Year | $1.49 | $64.28 |
| P/E Ratio | ★ N/A | $5.85 |
| Revenue Growth | ★ 23.26 | N/A |
| 52 Week Low | $3.71 | $2.53 |
| 52 Week High | $8.76 | $5.45 |
Technical Indicators
Market Signals| Indicator | ARKO | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 36.34 | 57.76 |
| Support Level | $4.20 | $3.36 |
| Resistance Level | $5.26 | $4.04 |
| Average True Range (ATR) | 0.19 | 0.20 |
| MACD | 0.11 | 0.03 |
| Stochastic Oscillator | 65.19 | 72.23 |
Price Performance
Historical ComparisonAbout ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. It derives the majority of its revenue from retail and wholesale distribution of fuel.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.